Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: Novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties
Authors:
- Marianne GünthelMGMarianne Günthel
- Sören KrawczykSKSören Krawczyk
- Marc HemmerMHMarc Hemmer
- Tom WersigTWTom Wersig
- Andreas LangnerALAndreas Langner
- Joséf MolnárJMJoséf Molnár
- Hermann LageHLHermann Lage
- Andreas HilgerothAHAndreas Hilgeroth
- 1 January 2013
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 21 (1) , 166-177
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical CancerClinical Cancer Research, 2011
- Delivery of short hairpin RNAs by transkingdom RNA interference modulates the classical ABCB1-mediated multidrug-resistant phenotype of cancer cellsCell Cycle, 2009
- The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein researchFEBS Letters, 2005
- MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line modelsBlood, 2003
- Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myelomaCancer, 2002
- Regioselective Formation of Novel Functionalized 1-Aza-9-oxafluorenesHETEROCYCLES, 2001
- The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi‐drug transporterInternational Journal of Cancer, 1993
- Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) seriesJournal of Medicinal Chemistry, 1988
- Diethyl 3,6-dihydro-2,4-dimethyl-2,6-methano-1,3-benzothiazocine-5,11-dicarboxylates as calcium entry antagonists: new conformationally restrained analogs of Hantzsch 1,4-dihydropyridines related to nitrendipine as probes for receptor-site conformationJournal of Medicinal Chemistry, 1987
- MECHANISMS OF REDUCTION OF ANTITUMOR DRUG TOXICITY BY LIPOSOME ENCAPSULATIONAnnals of the New York Academy of Sciences, 1978